Zentek(TSXV) ZEN

Zentek Ltd. is a Canadian company specializing in the exploration and advancement of graphene and related nanomaterials. The firm is known for its innovative ZenGUARD brand, which features a graphene-based antimicrobial coating used in various applications, including surgical masks and HVAC filters.

Products and Services

• Graphene-based antimicrobial coatings for personal protective equipment
• Point-of-care diagnostics leveraging graphene compounds
• Synthesis of graphene, graphene oxide, and quantum dots for diverse applications

Growth Outlook

• Expansion into healthcare markets with innovative graphene applications
• Increased demand for antimicrobial solutions amid global health concerns
• Strategic partnerships to enhance product development and market reach

Financial Highlights

• Recent quarterly revenue of CAD 0, reflecting ongoing development phases
• Cash and cash equivalents increased to CAD 16.6 million in Q1 2026
• Current ratio of 4.65 indicates strong liquidity position

Zentek Ltd. is positioned in the chemicals industry, focusing on cutting-edge graphene technology. The Albany Graphite project, fully owned by the company, serves as a critical asset for sourcing high-quality graphene. The ZenGUARD product line is gaining traction, particularly in the healthcare sector, where antimicrobial properties are increasingly valued. Recent financial data indicates a significant cash position, providing the company with the necessary resources to continue its research and development efforts. The current ratio suggests a robust ability to meet short-term obligations, which is crucial for sustaining operations during the development phase. Overall, Zentek Ltd. presents an intriguing opportunity for investors interested in innovative materials and their applications in various industries, particularly healthcare. The company's focus on graphene technology and its strategic initiatives may lead to substantial growth in the coming years.